Ngā hua rapu - Robb, Merlin

The transient HIV remission in the Mississippi baby: why is this good news? mā Ananworanich, Jintanat, Robb, Merlin L

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Lessons from acute HIV infection mā Robb, Merlin L., Ananworanich, Jintanat

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Harnessing circulating microRNAs for early HIV diagnosis mā Vasan, Sandhya, Robb, Merlin L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Accessories to SIV Control: T Cell Vaccination Shows Potential mā Robb, Merlin L., Bolton, Diane L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Broadly neutralizing antibody and the HIV reservoir in acute HIV infection: a strategy toward HIV remission? mā Ananworanich, Jintanat, McSteen, Brian, Robb, Merlin L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

HIV-1 vaccines: Challenges and new perspectives mā Excler, Jean-Louis, Robb, Merlin L, Kim, Jerome H

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Defining epitope coverage requirements for T cell-based HIV vaccines: Theoretical considerations and practical applications mā Currier, Jeffrey R, Robb, Merlin L, Michael, Nelson L, Marovich, Mary A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes mā Bai, Hongjun, Li, Yifan, Michael, Nelson L., Robb, Merlin L., Rolland, Morgane

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

W-Curve Alignments for HIV-1 Genomic Comparisons mā Cork, Douglas J., Lembark, Steven, Tovanabutra, Sodsai, Robb, Merlin L., Kim, Jerome H.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models mā Deming, Meagan E., Michael, Nelson L., Robb, Merlin, Cohen, Myron S., Neuzil, Kathleen M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines mā Excler, Jean-Louis, Ake, Julie, Robb, Merlin L., Kim, Jerome H., Plotkin, Stanley A.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Quantitative Analyses Reveal Distinct Sensitivities of the Capture of HIV-1 Primary Viruses and Pseudoviruses to Broadly Neutralizing Antibodies mā Kim, Jiae, Jobe, Ousman, Peachman, Kristina K., Michael, Nelson L., Robb, Merlin L., Rao, Mangala, Rao, Venigalla B.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection mā Matavele Chissumba, Raquel, Namalango, Eduardo, Maphossa, Vânia, Macicame, Ivalda, Bhatt, Nilesh, Polyak, Christina, Robb, Merlin, Michael, Nelson, Jani, Ilesh, Kestens, Luc

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis mā Colby, Donn J, Kroon, Eugene, Sacdalan, Carlo, Gandhi, Monica, Grant, Robert M, Phanuphak, Praphan, Ananworanich, Jintanat, Robb, Merlin L, Phanuphak, Nittaya

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Use of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 To Assess the Performance of Viral RNA Quantitation Tests mā Jagodzinski, Linda L., Wiggins, Debra L., McManis, Joshua L., Emery, Sandra, Overbaugh, Julie, Robb, Merlin, Bodrug, Sharon, Michael, Nelson L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Assessing Prevalence and Transmission Rates of Malaria through Simultaneous Profiling of Antibody Responses against Plasmodium and Anopheles Antigens mā Chaudhury, Sidhartha, Bolton, Jessica S., Eller, Leigh Anne, Robb, Merlin, Ake, Julie, Ngauy, Viseth, Regules, Jason A., Kamau, Edwin, Bergmann-Leitner, Elke S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Potent cellular and humoral immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use mā Wahren, Britta, Bråve, Andreas, Boberg, Andreas, Rollman, Erik, Birx, Deborah, Cox, Josephine, Robb, Merlin, Moss, Bernhard, Blomberg, Pontus, Biberfeldt, Gunnel, Sandström, Eric

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Timing HIV infection with a simple and accurate population viral dynamics model mā Reeves, Daniel B., Rolland, Morgane, Dearlove, Bethany L., Li, Yifan, Robb, Merlin L., Schiffer, Joshua T., Gilbert, Peter, Cardozo-Ojeda, E. Fabian, Mayer, Bryan T.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Resistance Is Associated with the Syncytium-Inducing Phenotype and Lower CD4 Cell Counts in Subtype CRF01_AE-Infe... mā Polonis, Victoria R., Souza, Mark S. de, Darden, Janice M., Chantakulkij, Somsak, Chuenchitra, Thippawan, Nitayaphan, Sorachai, Brown, Arthur E., Robb, Merlin L., Birx, Deborah L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging mā Ehrenberg, Philip K, Geretz, Aviva, Baldwin, Karen M, Apps, Richard, Polonis, Victoria R, Robb, Merlin L, Kim, Jerome H, Michael, Nelson L, Thomas, Rasmi

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa